Viewing StudyNCT00102518

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00102518
Status: COMPLETED
Last Update Posted: 2012-08-31
First Post: 2005-01-29
Brief Title: Aripiprazole Open-Label Safety and Tolerability Study
Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Organization: Otsuka Pharmaceutical Development Commercialization Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Bipolar Disorder
Schizophrenia
Keywords:
Name View
Bipolar I Disorder Manic or Mixed Episode View
Open Label View
Aripiprazole View